Other studies have suggested the relationship between RCC risk and polymorphisms in obesity-related genes, such as FTO and ADIPOQ, and genes in the mTOR signalling pathways [207,208,209]. This evidence concerns the gene ADIPOQ and renal cell carcinoma.